Metagenomi Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,887 | -25,148 | -68,255 | -48,961 | -29,141 |
| Depreciation Amortization | -726 | 22 | -5,007 | -4,500 | -3,191 |
| Accounts receivable | 803 | 369 | -2,451 | -3,924 | -2,328 |
| Accounts payable and accrued liabilities | 1,734 | 3,159 | -84 | 2,439 | 882 |
| Other Working Capital | -31,658 | -10,911 | -26,429 | -22,055 | -15,112 |
| Other Operating Activity | 9,575 | 2,659 | 10,817 | 6,184 | 1,803 |
| Operating Cash Flow | $-56,159 | $-29,850 | $-91,409 | $-70,817 | $-47,087 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,580 | -915 | -9,814 | -8,077 | -5,818 |
| Purchase Of Investment | -249,166 | -174,663 | -208,096 | -168,977 | -168,977 |
| Sale Of Investment | 142,978 | 80,846 | 263,644 | 162,156 | 84,008 |
| Investing Cash Flow | $-107,768 | $-94,732 | $45,734 | $-14,898 | $-90,787 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 84,505 | 86,537 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 1,012 | 2,346 | 4,256 |
| Financing Cash Flow | $84,505 | $86,537 | $1,012 | $2,346 | $4,256 |
| Beginning Cash Position | 145,851 | 145,851 | 190,514 | 190,514 | 190,514 |
| End Cash Position | 66,429 | 107,806 | 145,851 | 107,145 | 56,896 |
| Net Cash Flow | $-79,422 | $-38,045 | $-44,663 | $-83,369 | $-133,618 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,159 | -29,850 | -91,409 | -70,817 | -47,087 |
| Capital Expenditure | -1,580 | -915 | -9,814 | -8,077 | -5,818 |
| Free Cash Flow | -57,739 | -30,765 | -101,223 | -78,894 | -52,905 |